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background: Increased albuminuria indicates cardiovascular and renal damage in hypertension. RDN emerged as an innovative interventional 
approach to reduce blood pressure (BP) and may thus reduce albumin urinary excretion. The primary objective of this study was the effect of renal 
denervation (RDN) on elevated urinary albumin-to-creatinine ratio (UACR) in treatment-resistant hypertensive patients.
methods: Fifty-nine treatment-resistant hypertensive patients (≥ 140/90 mmHg with ≥ 3 antihypertensive drugs) with elevated UACR at baseline 
underwent catheter-based RDN using the Symplicity Flex™ catheter (Medtronic Inc, Santa Rosa, CA).
results: Six months after RDN both office (-18 ± 23 / -10 ± 13 mmHg) and 24-h ambulatory BP (-10 ± 14 / -6 ± 10 mmHg) were significantly 
reduced (p for all < 0.001). In parallel, UACR was reduced in all patients (160.5 (65.5-495.5) versus 88.6 (29.0-318.9) mg/g creatinine, p<0.001) 
and in those with microalbuminuria (83.5 (48.7-153.2) versus 58.1 (16.8-113.0) mg/g creatinine, p=0.001) and macroalbuminuria (536.4 (434.3-
1482.6) versus 478.3 (109.1-1079.6) mg/g creatinine, p<0.001). In accordance, the prevalence of micro- and macroalbuminuria decreased 
significantly. Regression analysis revealed a modest positive relationship between the decrease of UACR and the fall of systolic BP (β=0.337, 
p=0.045) independent of renal function. Renal function remained unchanged after RDN (68.4 ± 23 versus 66.9 ± 24 ml/min/1.73m2, p=0.270).
conclusions: In summary, following RDN, the magnitude of albuminuria as well as the prevalence of micro- and macroalbuminuria decreased in 
treatment-resistant hypertensive patients. Since albuminuria is an independent renal and cardiovascular risk factor, our findings suggest a reduction 
of renal and cardiovascular risk in these patients.
